Startup Observer.com
  • Home
  • Industries
  • Innovation
  • outsourcing
  • Business
  • Finance
  • Headlines
  • Opinion
  • News
Home News G20 want 70% of world vaccinated by mid-2022, sets up task force for pandemic fight
News

G20 want 70% of world vaccinated by mid-2022, sets up task force for pandemic fight

by jcp October 29, 2021
October 29, 2021
gawdo

By Jan Strupczewski and Andrea Shalal

ROME (Reuters) -Finance and health ministers from the world’s 20 biggest economies (G20) said on Friday they would take steps to ensure 70% of the world’s population is vaccinated against COVID-19 by mid-2022 and created a task force to fight future pandemics.

They could not reach agreement on a separate financing facility proposed by the United States and Indonesia, but said the task force would explore options for mobilising funds to boost pandemic preparedness, prevention and response.

“To help advance toward the global goals of vaccinating at least 40 percent of the population in all countries by the end of 2021 and 70 percent by mid-2022 … we will take steps to help boost the supply of vaccines and essential medical products and inputs in developing countries and remove relevant supply and financing constraints,” the G20 ministers said in a communique seen by Reuters.

The previous goal had eyed vaccinating 70% of the world’s population by the autumn of 2022.

“We establish a G20 Joint Finance-Health Task Force aimed at enhancing dialogue and global cooperation on issues relating to pandemic prevention, preparedness and response, promoting the exchange of experiences and best practices, developing coordination arrangements between Finance and Health Ministries, promoting collective action, assessing and addressing health emergencies with cross-border impact and encouraging effective stewardship of resources,” the statement said.

The ministers said they were setting up the new body because the COVID-19 pandemic had exposed “significant shortcomings” in the world’s ability to coordinate its response.

They pledged to support “all collaborative efforts” to provide access to safe, affordable, quality and effective vaccines, therapeutics, diagnostics, and personal protective equipment, particularly in low- and middle-income countries.

To reach the vaccination goals, they said they would work to boost the supply of vaccines and essential medical products and inputs in developing countries, while removing constraints on supply and financing, but gave no specific details.

They also called for boosting the resilience of supply chains through voluntary technology transfer hubs in various regions, such as the newly established mRNA Hubs in South Africa, Brazil and Argentina, and through joint production and processing arrangements.

The call for a voluntary mRNA technology transfer means that talks on the idea of a temporary waiver of intellectual property rights on COVID-19 vaccines and therapies – originally proposed by South Africa and India and now championed by the United States – remain stuck at the World Trade Organisation.

(Reporting by Andrea Shalal and Jan Strupczewski; Editing by Nick Macfie)

www.gawdo.com
Share on FacebookShare on TwitterShare on Linkedin
0 FacebookTwitterPinterestEmail
previous post
​​Infermedica symptom checker analysis reveals patients don’t seek medical help when they should
next post
Something phishy? Top tips for being cyber secure

You may also like

Prince William and wife Kate take over UK...

May 13, 2022

Soccer-Nike ends sponsorship deal with Spartak Moscow

May 13, 2022

Greece, Bulgaria say new LNG terminal will help...

May 3, 2022
Editorial & Advertiser disclosureEditorial & Advertiser disclosureOur website provides you with information, news, press releases, Opinion and advertorials on various financial products and services. This is not to be considered as financial advice and should be considered only for information purposes. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third party websites, affiliate sales networks, and may link to our advertising partners websites. Though we are tied up with various advertising and affiliate networks, this does not affect our analysis or opinion. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you, or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish sponsored articles or links, you may consider all articles or links hosted on our site as a partner endorsed link.
gawdo.com
https://www.gawdo.com
  • About us
  • Advertising & Terms of Use
  • Contact Us
  • Privacy Policy

@2021 - All Right Reserved.


Back To Top
Startup Observer.com
  • Home
  • Industries
  • Innovation
  • outsourcing
  • Business
  • Finance
  • Headlines
  • Opinion
  • News
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT